DPP-IV inhibitors, GLP-1 analogues to see strongest growth among Type 2 diabetes drugs through 2020, study finds
BURLINGTON, Mass. — Two classes of drugs for treating Type 2 diabetes will experience the biggest growth in market share of all classes of drugs for the condition, according to a new study by Decision Resources.
The study found that DPP-IV inhibitors and GLP-1 analogues would experience the biggest growth in market share among all drug classes, with a combined market share that will increase from 20% in 2010 to 47% in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
The report found that Merck & Co.’s Januvia (sitagliptin) dominates DPP-IV drugs and will consolidate its position, while GLP-1 analogues will have a strong position as well, with Novo Nordisk’s Victoza (liraglutide) having the opportunity to edge up due to delays in the launch of Bydureon (exenatide), a once-weekly GLP-1 analogue made by Eli Lily & Co., Amylin Pharmaceuticals and Alkermes.
Inspiring young Latinos to join healthcare field comes at critical time
WHAT IT MEANS AND WHY IT’S IMPORTANT — The news that CVS Caremark has partnered with the Hispanic Heritage Foundation to inspire and prepare young Latinos to join the healthcare field is not only positive in its own right but is especially important when you look at the fact that the nation’s Hispanic population is growing four times faster than the total U.S. population.
(THE NEWS: CVS Caremark, Hispanic Heritage Foundation partner to inspire future Latino healthcare leaders. For the full story, click here)
As the article states, through a new healthcare category of the HHF Youth Awards program, CVS Caremark and HHF will recognize this fall and winter more than 30 high school seniors of Latino descent for their academic performance, community service and interest in pursuing a career in health care.
Providing opportunities for career development and aiming to bolster the number of young Latinos pursuing traditional and nontraditional healthcare careers is essential. According to the U.S. Census Bureau, between 2000 and 2010, the Hispanic population grew by 43% — four times the nation’s 9.7% growth rate. The Hispanic population grew in every region of the United States between 2000 and 2010, with the most significant growth occurring in the South (a 57% increase) and the Midwest (a 49% increase), according to the U.S. Census Bureau. While the Hispanic population grew at a slower rate in the West and Northeast, the regions still saw significant growth. The Hispanic population in the West grew by 34% and by 33% in the Northeast.
Furthermore, a September 2011 special report by IBISWorld on the growing Hispanic population stated that over the next five years to 2016, the Hispanic contribution to the colleges and universities industry is projected to grow at an average annual rate of 5.1% to $44 billion. "Institutional and government programs that promote minority and low-income college attainment will continue to boost the Hispanic contribution to higher education," the report noted.
Clearly, the Hispanic population is a vital market. Now, factor in the fact that some 32 million uninsured will gain coverage beginning in 2014, amid an ongoing primary care physician shortage. The U.S. healthcare system already is overflowing, and finding ways to encourage youth to pursue careers in health care is critical.
CDC: Reductions in heart disease rates vary by geography, race, ethnicity
ATLANTA — Despite declines in the number of Americans reporting coronary heart disease, rates vary widely between states and between racial and ethnic groups, according to a new study by the Centers for Disease Control and Prevention.
The CDC’s "Morbidity and Mortality Weekly Report" found that between 2006 and 2010, the number of people reporting that a health professional had told them they had coronary heart disease — a term that comprises heart attacks and chest pain — had declined overall from 6.7% to 6%. The decline was the result of reductions in the number of people who smoke, who have uncontrolled high blood pressure and cholesterol, and improvements in treatments for heart disease.
Nevertheless, the highest rates of self-reported coronary heart disease were found among elderly people, of whom 19.8% reported having it, and among Native Americans and Alaskan Natives, who displayed rates of 11.6%. In addition, while Hawaii and the District of Columbia showed low prevalences (3.7% and 3.8%, respectively), states in the South showed much higher rates, with the highest prevalence (8.2%) in West Virginia and Kentucky.
"Where you live and how you live matters to your heart," CDC director Thomas Frieden said. "The Million Hearts national initiative, which can prevent 1 million heart attacks and strokes over the next five years, focuses on actions people can take themselves and actions that businesses, communities and health providers can take to prevent heart attacks and strokes today."